Tesla reported record first-quarter results with vehicle sales climbing despite a delay in its revised Model S and chip shortages. The numbers, however, may not be as good as they seem when you look at the special circumstances that led to the company being profitable. Steve Symington joins Dan Kline on Wednesday’s “7investing Now to break down the numbers and look at what’s next for the visionary automaker. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

In this conversation, 7investing Lead Advisor Matthew Cochrane sits down with Eric Clark, a brand strategist and dedicated investor in leading global consumer brands. Clark believes that a strategy solely dedicated to investing in the world's best consumer brands. Clark does not think that a portfolio solely dedicated to consumer brands is limiting but is a distinct advantage. With consumer spending topping about $40 trillion a year, Clark believes the world's greatest companies are found in this space, and there is little competition that focuses exclusively on this sector. Clarks breaks down brands into three categories:   Mega brands represent the core of the portfolio, and all have a real chance to reach a $1 trillion market cap. These companies are highly recognizable and market leaders in their respective industries.  Innovator brands are those companies that are competing with and trying to disrupt the legacy leaders in their fields. These stocks can be more volatile but offer higher upside.  Turnaround brands, or tactical trading ideas, are investment opportunities more short-term in nature, stemming from the market discounting the company's stock based on the latest news rather than the company's long-term potential. The conversation soon turned to the state of the economy, especially consumer spending. Clark believes that with higher savings rates, jobs coming back, and extended government aid such as extended unemployment benefits and stimulus checks, that the economy has a chance to appreciably rebound as it re-opens. Along the way, Clark and Cochrane discuss companies such as Apple (NASDAQ:AAPL), Domino's Pizza (NYSE:DPZ), Netflix (NASDAQ:NFLX), and Tesla (NASDAQ:TSLA), their mutual love for San Diego, and how they teach their kids about investing.    Clark can be found on Twitter @dynamicbrands, and you can find out more on his brand research on his website, globalbrandsmatter.com.

Whether you’re on social media or watching mainstream media, much of the investment advice you hear will be terrible. On Monday’s 7investing Now, Dan Kline and Maxx Chatsko talk about some of the worst investing advice that’s commonly given out. We’ll also talk whether psychedelics offer an investment opportunity and Anirban Mahanti will join the program to talk about how he invests his family’s money. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The pandemic combined with low interest rates have caused some major upheaval in the housing market. Housing prices have been skyrocketing in many markets and availability has been scarce. Can that continue? Are we in a bubble? Simon Erickson and Matt Cochrane join Dan Kline to break down the housing market on the Friday edition of 7investing Now. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

You don’t need 7investing to tell you how Apple is the trendsetter when it comes to consumer technologies. So, no wonder, when Apple has a product event, everyone pays attention. This week Apple’s “Spring Loaded” event landed. Apple announced a new iPads, new iMacs, a refreshed Apple TV, some service enhancements, and a brand new product called Apple AirTag. 7investing Lead Advisors Dan Kline and Anirban Mahanti sat down to discuss what impressed, what didn’t, and how all of this fits into Apple’s long-term strategy. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Investors are already quite familiar with several of the biggest trends taking shape in the tech world. Artificial intelligence, autonomous vehicles, e-commerce, and digital streaming are huge movements that are attracting hundreds of billions of dollars all across the globe. The companies who are leading these trends — such as Microsoft, Amazon, and Netflix — are also attracting hundreds of billions of dollars in their stock market valuations. Several growth-style investors who are intrigued by these trends might want to find smaller opportunities who haven’t already become the market’s largest companies. But perhaps there is a less obvious and more creative way to invest in the world’s largest tech trends. And we reached out to an expert in the space to learn more. Sean O’Hara is the President of Pacer ETFs, an ETF issuer with more than $5 billion of assets under management. His team is investing in the critical infrastructure that is crucial to support the developing tech trends, such as datacenter buildings and cellular tower operators. Several of these companies are organized as publicly-traded Real Estate Investment Trusts (“REITs”), and they’re benefiting from the exponential growth of data. In an exclusive interview with 7investing, Sean describes “the four horsemen of the internet” and explains why 5G is such a big deal. He reveals who will be the largest beneficiaries of increasing cellular traffic, and what companies could be the hidden gems that are still off the radar of most investors. Sean also describes several other ETF strategies, such as identifying “global cash cows” with high free cash flow yields and how his firm is investing in China. Sean and Simon also have some fun sharing thoughts about self-driving cars and how some companies represent Texas bovine. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The market can be a volatile place. A few years ago, the prices of cannabis stocks got fired up but ended up going up in smoke. Cryptocurrencies have gone from cashing in to cashing out. And GameStop went from "game on" to "game over" within a few short weeks. Stock prices can shoot to the moon and then come crashing back down to Earth in short periods of time. But it's important to recognize the difference between short-term momentum trading and long-term growth-style investing. In the latter, investors can methodically identify and invest in disruptive companies who are capitalizing on larger trends. And because they are still unknown or underappreciated in the public markets, early investors can create fortunes by buying-and-holding them over long periods of time. This growth-style investing approach is exactly what is preferred by 7investing founder and CEO Simon Erickson. In a conversation with Robert Leonard of Millennial Investing, Simon describes his investing process and what it means to be a growth-style investor. He explains the drivers of why stock prices go up (or down) over time, the role of leadership in valuation, and a few landmines investors should always avoid. He and Robert also compare investing to Texas Hold Em, give a few investing book recommendations, and offer advice for those getting started with investing. Publicly-traded companies mentioned in this interview include Berkshire Hathaway, Nuance Communications, and Tesla. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Retail isn't dying. It's just evolving.   Companies with an established physical presence are leveraging the internet to reach customers. And while new digital trends like direct-to-consumer are certainly taking shape, retail concepts like brand loyalty and customer focus are still just as important as ever.   7investing lead advisor Dan Kline is an expert on the retail industry and has hand-selected several recommendations from this industry. In this exclusive interview, Dan chats with 7investing CEO Simon Erickson about the most important changes underway in retail. The two discuss e-commerce, the new face of malls, stores-within-stores, and a few trends worth watching closer. Dan also describes why brand matters more now than ever and a few retail companies which are on his shopping list as an investor.   Publicly-traded companies mentioned in this interview include Adidas, Dick's Sporting Goods, Dollar General, Nike, Nordstrom, Target, The TJX Companies, Ulta Beauty, and Under Armour. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

We’re really excited to introduce the seventh member of the 7investing lead advisor team. Once we make the big reveal we’ll be talking about three key trends in healthcare. We’re heading toward some major disruptions in a space that impacts all Americans. We’ll look at what this might mean for investors and how the market may change. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Whether we've fought our battles or helped family or friends with their own, cancer has likely impacted all of us. Malignancies are the leading cause of death among individuals under the age of 85 and are responsible for 9.5 million deaths globally each year, including an estimated 600,000 in the United States. But there are many reasons for optimism. Our deepening understanding of biology and the genetic root causes of disease are leading to better, earlier, and safer treatment options. The burgeoning field of liquid biopsies and other next-generation diagnostics allow us to detect cancers earlier and monitor recurrence in survivors, which promises to greatly improve survival rates. New therapeutic modalities ranging from genetic medicines to cell therapies to bispecific antibodies create opportunities for personalized treatments that are highly effective. It can be difficult for investors to keep track of the rapidly advancing scientific frontier, but there won't be an excuse this week. The American Association for Cancer Research (AACR) Annual Meeting 2021 is being held virtually from April 10 through April 15. As a scientific meeting, many companies will be presenting updates on key preclinical and clinical assets -- for the first time publicly, in some cases -- with a bias towards earlier-stage assets. Scientists across academic institutions, non-profit research centers, and industry will also gather to discuss challenges and opportunities for specific technologies ranging from the use of natural killer (NK) cells in cancer treatment, choosing biomarkers for liquid biopsy diagnostics, the role of artificial intelligence and machine learning in drug discovery and disease monitoring, and many more. Given the focus on early-stage assets, investors might not expect too many market-moving announcements. However, AACR will be a great time to check in on your investment thesis for a specific company or technology, get a better glimpse of the competitive landscape, and put new technologies on your radar for the next few years. For example, investors who kept pace with similar scientific meetings in recent years would have seen the massive market opportunities for liquid biopsies and potentially made life-changing investments in the pioneers. Topics discussed in this episode include next-generation diagnostics for tracking minimal residual disease (MRD), next-generation bispecific antibodies, and precision oncology. To view the full program, abstracts, and more, please visit the AACR Annual Meeting 2021 website. Publicly-traded companies mentioned in this podcast include Adaptive Biotechnologies, Agenus, Eli Lilly, Exact Sciences, Guardant Health, Illumina (via proposed acquisition of Grail), Invitae, Merus, NeoGenomics, and Xencor. 7investing Lead Advisors may have positions in the companies that are mentioned. This interview was originally recorded on April 5th, 2021 and was first published on April 8th, 2021.

7investing Lead Advisor Matthew Cochrane was happy to welcome back The Science of Hitting to the podcast for another conversation covering a wide gamut of companies and financial news.      After writing more than 800 articles on GuruFocus over the last nine years, The Science of Hitting is moving to Substack, where he will post new research ideas, personal portfolio updates, and higher-level thoughts on investment philosophy. He says, "I essentially view this as an opportunity to take the work I've done on Gurufocus over the past decade a step further, to really open up everything about my thoughts and actions as an investor with subscribers."    When discussing whether he uses complex discount cash flow analyses when valuing stocks, Science of Hitting says he hopes he has found a happy medium between using back of envelope math or financial modeling that employs dozens of unknowable variables. While he uses models to see what earnings and free cash flow might be five years down the road, the bigger rationale for doing it is discovering the business's most significant drivers. For instance, it can help when studying retailers to determine if store expansion or same-store sales growth is more critical to the company's future.   The two look at the market, discussing whether re-opening economy plays are already getting ahead of themselves. Matthew notes that the U.S. Global Jets ETF (NYSE:JETS) is only slightly off its pre-pandemic highs and the Invesco Dynamic Leisure and Entertainment ETF (NYSE:PEJ) is slightly above its pre-pandemic price. Science of Hitting shares that he sold longtime position Booking Holdings (NASDAQ:BKNG) based on valuation concerns. He noted Booking's stock price was about $2,000 heading into the pandemic before getting cut in half, but that it had now recovered to about $2,400. That's 20% above where it traded pre-pandemic despite management cautioning it might take years before its business fully recovers from COVID's impact.    While discussing economic re-opening plays, the discussion turns to Vail Resorts (NYSE:MTN), the owner-operator of the majority of the most popular ski resorts in the U.S. and around the world. Vail recently cut its season pass prices by 20%. With the number of active skiers seemingly in secular decline, many wonder if this is a desperate attempt to lure new skiers to its resorts or leverage its scale and competitive positioning to kick its competitors while down.   Science of Hitting also gave his take on Spotify's (NYSE:SPOT) recent acquisition of Locker Room, a live audio app used for fans and insiders to talk about sports. Overall, it was a relatively small sum Spotify spent to secure the deal while it has the potential to now participate in a massive step of audio's evolution.

The FDA has cleared the single-source Nano.ARC machine, which will be used in tomosynthesis applications (checking for breast cancer). It’s a big step for the company which takes away some risk for investors in the company. This is a major milestone for Nano-X but much work remains and there are still manufacturing and distribution hurdles to be cleared. We’ll also be talking Nike and its efforts to go direct-to-consumer which has shut out some major retailers. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Every month, our team of Lead Advisors is each asked the same question, which is, "what is your very best idea in the stock market right now?"If you are a 7investing subscriber who has seen our reports answering that question, you know we look at metrics beyond just the reported earnings per share and the company's revenue.  We love to dig into the profitability ratios, operating margins, and other metrics that will drive that business over time.But how exactly do we learn about those metrics and transparently relay our findings to our subscribers? To help, we partnered with YCharts, a full-service fundamental research platform for investors. While we use YCharts here at 7investing almost every day, we thought it would be fun to bring our partnership to the listeners of our Livestream! We dug into several companies, including Alnylam Pharmaceuticals, Criteo, CVS, Facebook, NVIDIA, Rocket, Square, 2U, and Veeva - and greatly appreciated having the exceptional team from YCharts on hand to spin up graphics on the spot. Our mission at 7investing is to empower individual investors, and our friends at YCharts are a great resource to supplement your 7investing subscription. For a limited time, YCharts is offering a discount on their service to all 7investors! Use code "7investing" at checkout for a 20% discount. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Robots have already found their way onto the factory floor. Now they're finding their way into the operating room.   We're seeing a prominent rise in the adoption of surgical robots, and it's driving a wave of acquisitions from larger medical device companies. Smaller, independent robotics companies are being bought-up at a significant premium to their current market capitalizations. And that spells opportunity for investors.   But how can we find these smaller acquisition targets? And if they stay independent, will they be able to hold their own against much larger competitors in this space?   To help us answers these questions, we've brought in a few experts. Brian Gahsman is the Chief Investment Officer of the Contego Capital Groups and the Portfolio Manager of the AlphaCentric Robotics and Automation Fund (GNXIX). He has first-hand experience with medical robotics (literally!) and is on the hunt for small and micro-cap robotics companies.   In this exclusive interview, Brian and his analyst Jin Kwon are joined by 7investing CEO Simon Erickson and lead advisor Steve Symington. The group talk about about how COVID has positivity impacted the robotics industry this past year and how 5G could be a sneaky way to play the robotics trend. They also discuss several smaller robotics companies such as Stereotaxis and Accuray, and what makes them so appealing as acquisition targets for larger players. Finally, they discuss the competitive position of Intuitive Surgical (Nasdaq: ISRG) and what factors are driving the adoption of medical robotics.   Publicly-traded companies mentioned in this interview include Accuray, Intuitive Surgical, Medtronic, and Stereotaxis. 7investing's advisors or its guests may have positions in the companies mentioned.    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

We’ve got a huge announcement to kick off the show. Simon Erickson will be joining Dan Kline to introduce our newest lead advisor. After that, our new advisor, Simon, and Dan will be talking about why the current stock market situation isn’t comparable to the 90s stock bubble. Yes, there are a lot of highly-valued tech stocks, but that does not tell the whole story. And, to close the show, we’ll be sharing some of the best investment advice we have ever received. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Our 7investing team podcast for March is all about asset allocation! Our team describes how they buy new companies, establish position sizing, and define a diversified portfolio. They also offer important advice for new investors who are just getting started. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The housing market has been on fire and that can make it a very confusing time for anyone looking to enter it. You might be buying during an overinflated market or waiting too long in one that’s going to continue to rise. That creates a dilemma for millennials might be buying their first homes (and really for anyone deciding to buy or sell.   Francesca Ortegren, a data scientist for Clever joins 7investing lead advisor Dan Kline to talk about some research her company has conducted that gives it some special insight. Ortegren co-authored her company’s 2021 Millennial Homebuyers Report. In that study, Clever learned that many younger buyers were more open to fixer-uppers and that their saving habits have changed.   The study showed that millennials are more willing to buy sub-optimal houses that need major work. They’re also more willing to buy home sight unseen where they have only seen pictures or taken an online tour. Ortegren also shares her thoughts on long-term changes being brought on by work-from-home flexibility and her thoughts on FOMO.    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

In celebration of our one year anniversary, the 7investing team will all be on 7investing Now to share our top investing advice and take your questions. Each of us brings a different perspective to investing and we’ll talk about some of the principles that guide us on our investing journey. We will also take your questions and throw in a few surprises. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Want to see even more in-depth cloud computing coverage from Matthew? Check out his newly-launched hypergrowth blog and Twitter handle @hhhypergrowth! Cloud computing has been one of the stock market's best-performing sectors in recent years. Rather than building out their own IT infrastructure, companies are hiring cloud service providers for the computing, storage, and networking they need to expand their web-based businesses. On top of that cloud-based infrastructure, companies are building "software as a service" solutions, which are catching on quickly and disrupting industries. But within the vast realm of cloud computing, certain opportunities are emerging as the most lucrative. Cloud-based databases, enterprise search, and cybersecurity are all extremely scalable activities which are winning share in markets that are worth tens of billions of dollars. For investors, finding the right companies within this space could be extremely profitable. To help us find those winning companies, 7investing brought in a cloud computing expert. Matthew Eash is a data architect for the National Renewable Energy Laboratory. A software developer for decades, he has embraced learning about the technical details of the cloud in order to discover its most promising companies. In an exclusive interview with 7investing, Matthew describes why companies are undergoing a "digital transformation" and why cloud computing is so important. He explains the market opportunity for several cloud-based applications, as well as the companies who are most likely to benefit from them. Matthew also participates in a "lightning round", where he shares his thoughts about several cloud-relevant topics. Publicly-traded companies mentioned in this interview include Alphabet, Amazon, CrowdStrike, DataDog, Elastic, FireEye, Microsoft, MongoDB, Netflix, New Relic, Okta, PagerDuty, and Zscaler. 7investing's advisors and/or guests may have positions in the companies that are mentioned. This interview was originally recorded on April 30, 2020.

It’s hard to imagine that Tuesday marked one year since the stock market crashed as the impact of the coronavirus first became evident. It was a short-lived drop as markets recovered quickly and some stocks even soared to new heights. We’ll look back at the wild ride of the past year and peak into the future as vaccines make it seem possible that the pandemic will soon be something that’s an unpleasant memory, not something that shapes our world. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Non-fungible tokens are taking the world by storm.   These uniquely-identifiable and digitally-trackable NFTs are becoming a big hit with collectors across the world. Character cards, sporting highlights, and comic-book heroes are now being minted as NFTs. And due to their exclusivity, they're often attracting top-dollar bids through online auctions.   But the ability for NFTs to be digitally-tracked throughout their existence could be an even more intriguing quality. That means the original content creators can be paid in the upfront sale, but also in all future transactions of the asset they created. That could have huge implications for larger markets such as music and entertainment. Square's recent $297 million investment for a majority stake in TIDAL seems to suggest that NFTs could be disruptive to many industries.   What will all of this mean for investors? Where will NFTs most likely gain adoption, and are there specific companies who are best-poised to benefit?   For answers to those questions, we've brought in an NFT expert. In this 7investing exclusive interview, 7investing CEO Simon Erickson chats with JoelComm. Joel is a New York Times best-selling author and international speaker. He has also minted more than 500,000 non-fungible tokens and has seen this trend evolve from the beginning.   In their conversation, Joel explains to Simon how to purchase NFTs and where they're currently being used. He describes where the industry is heading and which companies are likely to embrace them. And finally, he even gives a live demo of his very favorite NFT purchase.   Publicly-traded companies mentioned in this interview include Alphabet, eBay, Disney, Hasbo, Mattel, and Microsoft. 7investing's advisors or its guests may have positions in the companies mentioned.

Everyone has a different level of risk tolerance. Volatile markets, however, can make anyone questions their own decisions when it comes to the makeup of their portfolio. The reality is that long-term investors don’t make decisions based on what’s happening in the market now. They buy good companies and hold them for a long time. That does not mean avoiding risk. Instead, it’s about figuring out what level of risk you’re comfortable with and understanding that even good companies may have major dips (often for silly reasons).

Peloton has built a devoted audience and it clearly stands as the premier player in connected fitness. But, at over $1,800 for its entry-level model and $40 a month for classes, it’s an expensive proposition for some people. Sam’s Club is now selling a copycat bike from Echelon for $799 with six months of free classes. Will that impact Peloton? We’ll also be joined by Alan Soclof of the Cruising Altitude newsletter to talk about millennials and investing.

Containers are taking the software world by storm. Virtually all new software development is now being done with "containers", which are entirely new ways to isolate individual components of software in a way that doesn't interfere with the rest of the application. Netflix was a company who was an early adopter of containers. And now, this appears to be an undeniable trend within the technology world. But how do containers work, and how are they so useful? And what will this mean for the software companies that we invest in? In this two-part 7investing exclusive interview series, we chat with DevOps expert Anand Khatri about containers. Here in Part 2, Anand discusses which companies could be excellent investments based upon this fast-growing trend. Publicly-traded companies mentioned in this interview include Alphabet, Netflix, and VMware. 7investing's advisors or its guests may have positions in the companies mentioned. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Non-fungible tokens (NFTs) appear to have popped up over night. What exactly are they and what might they mean for investors? Simon Erickson has a breakdown of this emerging technology and some of the exciting ways it’s already being used. In addition, Roblox had filed for a direct listing bringing the much discussed company public and Matt Cochrane will have all the details.

The software world is undergoing a fundamental change. There is a trend brewing of using "containers" for new software development. Technically, containers offer a way to build and isolate the code and dependencies of individual software components, in a way that doesn't interfere with the rest of a larger application. Bigger-picture, this allows apps to be built more quickly, more reliably, and more scalably. Innovative companies like Netflix (Nasdaq: NFLX) were early-adopters of containers. They used them to build out a robust ecosystem that could continually be updated and improved. And while cutting-edge software developers have embraced containers, overall mass-market adoption still remains very low. That could be a huge opportunity for investors. In this two-part 7investing exclusive interview series, we chat with DevOps expert Anand Khatri about containers. Here in Part 1, Anand explains what containers are, how they're different from traditional approaches, and what pain-points they are solving. Simon and Anand also describe microservices, orchestration systems, and monitoring agents -- and what roles these play in the biggest picture. This podcast lays the groundwork for our upcoming Part 2 (which will publish on Thursday), Anand describes several publicly-traded companies that could be excellent investments in this fast-growing trend. Publicly-traded companies mentioned in this interview include Alphabet, Amazon, Datadog, Microsoft, Netflix, and VMware. 7investing's advisors or its guests may have positions in the companies mentioned.

Congress has passed the latest (and presumably last) round of coronavirus stimulus. The package includes $1,400 checks for many Americans as well as extended unemployment benefits. It also includes billions for airlines which have not been required to do all that much in order to receive tens of billions of federal dollars. What impact will this stimulus have on the economy and what does that mean for the stock market? Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Investors and the market can sometimes have a very strange reaction to success. Instead of valuing the numbers a company has just reported, investors may hold those numbers against the company. It’s a case of “sure, these are great,” but can you do it again? Is that how investors should be looking at companies? Matt Cochrane and Simon Erickson will answer that question and share some amazing stocks that can currently be bought at bargain prices. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Is the market getting frothy? With some of the valuations for sexier stocks looking a little bit stretched, 7investing Lead Advisor Matthew Cochrane sat down with Lawrence Hamtil, a co-founder of Fortune Financial Advisors, to look at some companies with durable economic moats in industries that might be overlooked by most investors, including tobacco and defense.    Their conversation begins, however, with a comparison between valuation metrics of the U.S. stock market and international markets. Hamtil explains that while international markets often look cheaper at first glance, that once other factors such as sector allocation are taken into account, most of the gap in valuation can be justified.   Defense companies such as Lockheed Martin (NYSE:LMT), Northrop Grumman (NYSE:NOC), and General Dynamics (NYSE:GD), feature several moats unique to the industry. The industry supports several oligopolistic characteristics, Hamtil explains, as the U.S. government would only reluctantly seek militarized weapons deals from international corporations and companies must clear several regulatory hurdles before being approved for large multibillion-dollar deals.    While the tobacco industry is frowned upon by many in the investment world, Hamtil looks at it a bit differently, reasoning that the tobacco companies don't need investor money and return most money to shareholders. Shareholders can then put that money to use however they best see fit. With tobacco companies sporting cheap valuations and high dividend yields, Hamtil believes that many investors' portfolios would benefit by considering the companies for inclusion.   Hamtil can be found on Twitter with his handle @lhamtil and blogs at Fortune Financial Advisors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

It’s a busy week with a number of major retailers reporting earnings including Target and Kohls. Both delivered good numbers but what do they mean for the future. In addition, another retailer, Nordstrom’s, has entered into a partnership with fitness brand Tonal. Can this type of deal help make the company relevant to a new audience? In addition, Johnson & Johnson has an unlikely new partner helping it ramp up vaccine production. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The investment world is experiencing a unique cultural moment. Between the frictionless brokerage experience Robinhood offers, the rise of TikTok showcasing 30-second videos of questionable investment advice, and Reddit channels uniting thousands of individual investors at once, investing has never been more accessible to so many. But are the lessons that new investors are taking away from these experiences good? Joining 7investing founder Simon Erickson and lead advisor Matthew Cochrane to discuss these phenomena is returning guest Bill Brewster, the podcaster extraordinaire who serves as the host of The Business Brew and a co-host of the Value: After Hours. The three first look at Robinhood, the popular brokerage app used by so many new investors. Yes, a brokerage company’s main duty is to act as a middleman that connects buyers and sellers of stocks, bonds, and other assets. But beyond facilitating trades, the three co-hosts discuss several areas where Robinhood seemingly falls far short of ideal: Cochrane points out that Robinhood does not support Roth or traditional IRAs, two types of retirement accounts that feature extremely beneficial characteristics to American investors. Erickson takes aim at how the brokerage makes money, through the controversial practice of taking payments for order flows. Brewster highlights Robinhood's lack of customer support, telling a powerful personal story that drives the point home. The three also discuss the Gamestop (NYSE:GME) saga and the driving forces behind it. They wrap up the conversation addressing Michael Burry's recent tweets on inflation, including how investors can best position their portfolios to prepare for it.

It’s the first of the month -- a big day in the 7investing universe -- and we’re really excited about our March picks. We’ll celebrate by talking about the new Johnson & Johnson single-dose vaccine that the FDA just approved and we’ll look at whether it makes any sense to move into “recovery” stocks as the economy begins to move more toward normal. The answer isn’t simple and it probably isn’t what you're hearing elsewhere. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Many businesses exist not just to create profits, but to serve a higher-level purpose. A company's mission statement lays out the ambitions it ultimately wants to achieve. It typically describes a desired improvement to the status quo: whether that be making life easier for customers, innovating with new technologies, or even seeking a bigger-picture societal impact. The mission statement can also influence how the business itself operates. It often serves as the conscience that steers acquisition or capital allocation decisions. It can set a unified company culture that impacts hiring, and can and even can be a guide for specific projects. Examples of famous mission statements include Alphabet's quest "to organize the world's information and to make it universally accessible and useful" or Chipotle's goal "to provide food with integrity." We recently put some deeper thought into what role these mission statements should play in our objective investing research. Are there specific things within them -- either good or bad -- that we should pay closer attention to when searching for stock market opportunities? In this month's 7investing Team Podcast, our advisors describe how mission statements influence their investing research. We also provide a few companies whose mission statements are particularly compelling. And in the second segment of our podcast, we play a game of "Bullish or Bearish". Each advisor shares their thoughts about recent developments in an investing space they closely follow.

The pandemic has made the stock market even more volatile than usual. You have days like Tuesday where most stocks were deeply in the red for much of the day before many staged an afternoon rally. That can be hard to watch as an investor, but if you’re a long-term investor, these kind of moves should not change your mindset, That’s easier said than done for many people, but we’re here at 7investing to help you know what to do when the market makes big moves. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

You don't need 7investing to tell you that investors are experiencing a historic bull market. To put it mildly, investors are increasingly optimistic. About what? Well, that's a question worth asking. Investors are increasingly optimistic about the pace of the economic recovery -- at the macro level, anyway. It's not farfetched to expect record amounts of cash and wealth generation, which has been primarily "trapped" within equities and real estate in the last 12 months, to be unleashed in other parts of the economy as the pandemic loosens its grip. That would usher in a swift economic recovery unlike anything in recent memory, perhaps ever. Investors are also increasingly optimistic about innovation. Although that's not necessarily misplaced, individual investors must guard against unbounded optimism and remain objective. This is especially true when it comes to biotechnology and genomics. On the one hand, we're making significant advances in our understanding of biology that allow us to standardize biological parts. If we can standardize living systems, then we can engineer them with reproducible results. And if we can apply engineering principles to biology, then we can use biology as technology to improve medicine, industrial processes, agriculture, and much more. On the other hand, biology remains incredibly complex. The optimism surrounding certain trends, such as the "genomics revolution" or CRISPR gene editing, often dumbs down the complexity of biology to make the opportunities easier to understand for non-experts. Unfortunately, that also makes it easier to dismiss or completely overlook important risks facing new technologies. As company valuations become more and more distorted, those risks become amplified. One of the problems with the level of optimism in the current stock market is simple: It has become easier to buy tickers than to invest in businesses. Many biotech stocks are trading on momentum and stories alone. Today, we're increasingly seeing several years of revenue growth and clinical trial results or regulatory milestones -- which have yet to be achieved -- to be priced into biotech stocks. This can lead to disastrous outcomes when the stories fall apart or future events don't play out quite as investors expect. 7investing Lead Advisors Manisha Samy and Maxx Chatsko sat down to discuss the importance of balancing optimism with objectivity, the dangers of chasing story stocks and momentum stocks, and why your research into biotech stocks and genomics stocks should expand beyond social media or FinTwit. Most important, they remind all investors to seek information, not confirmation and discussed the following companies as examples: Amyris (NASDAQ: AMRS) Bionano Genomics (NASDAQ: BNGO) CRISPR Therapeutics (NASDAQ: CRSP) DermTech (NASDAQ: DMTK) Editas Medicine (NASDAQ: EDIT) Gevo (NASDAQ: GEVO)

The iPhone changed the definition of “phone” and led to an era where smartphones are ubiquitous. But that revolution occurred back in 2007 and smartphone sales have already hit their peak. That has left big tech companies searching for the next big thing. Will it be augmented reality or maybe something in the heath tech space? Maxx Chatsko joins Dan Kline to look for “next big thing” investing opportunities. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Walmart had massive online sales growth and impressive same-store numbers, but it did not meet analyst expectations when it came to profits -- largely because of investments it has made in infrastructure and people. Are analysts looking at the right things when they judge success or failure in retail? We’ll hit many of the same questions for Shopify and dig into how digital and delivery have changed the marketplace. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The space economy is picking up speed. Once considered an uninvestable sector, the entire sector is now attracting the attention of entrepreneurs and small businesses. Between the miniaturization of satellite components and a 10x reduction in the cost of rocket launches, the final frontier is finally becoming economically affordable for a new wave of space-borne ventures. Even though this makes for great news headlines, what will the new space race mean for investors? Are there specific commercial applications that offer the greatest opportunities? What impact will these newly-launched technologies have on the rest of our Earth-bound businesses? I spoke about those topics with disruptive innovation specialists James Wang and Sam Korus of ARK Invest. ARK’s thematic ETFs invest in several of the most innovative companies in the world (and beyond). As you might expect, they’re also quite interested in outer space. In our conversation, James, Sam, and I discuss why the commercial space economy should be on the radar of investors. I describe why imaging and sensing could become “the next GPS”, Sam explains the impact of miniaturization on satellite costs, and James compares satellite internet with 5G for the future of connectivity. We also describe how the coronavirus could create several long-term opportunities for investors, especially in enterprise software and in healthcare. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Berkshire Buys Verizon and Chevron Shares. Has Warren Buffett Lost His Touch? The Oracle of Omaha has disclosed that his company has take stakes in Chevron and Verizon. These aren’t exactly bold moves and they won’t convince anyone that the one-time genius may have lost something off his fastball. Has Berkshire Hathaway lost its way and is its leader out of touch with current markets? Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

7investing and CryptoEQ recently announced a partnership, to help investors get a better consolidated view of the opportunities in both equities and in cryptocurrencies. 7investing provides its top seven stock market recommendations every month, while CryptoEQ provides its top-rated cryptocurrencies. The two companies are now joining forces on a monthly basis, to discuss the most important recent developments taking place and the impact they'll have on both equities and crypto. This past month, that conversation included a discussion about Tesla's "audacious" commitment to buy $1.5 billion worth of Bitcoin for its corporate treasury, as well as Coinbase coming public at a valuation of up to $75 billion. Going forward, 7investing will publish the full video of these conversations to subscribers as a monthly Advisor Update. CryptoEQ will publish a written recap of the conversation with additional context in their monthly subscriber email newsletter. We've also decided that we'll be providing this first episode for free! We hope you enjoy the show and our takeaways as a part of our 7investing podcast series. If you'd like to gain access future shows, please consider becoming a subscriber by visiting 7investing.com/subscribe or cryptoeq.io/#memberships Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

We’ve heard a lot recently about how the individual investor can’t compete with the big guys and hedge funds. That’s true when it comes to being a trader -- you can’t beat the computers and the big money. The little guy, however, has one advantage, time. Being a long-term investor can bring incredible returns but it takes patience. It’s not easy for everyone to deal with the ups and downs of the market but if you buy-and-hold good companies you will make money in the long run. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

It has been a mixed pandemic for the Walt Disney Company. The Mouse House has seen its theatrical business go away and its theme parks operate at limited capacities or not be able to open at all. On the positive side, the company’s streaming platforms have shown explosive growth which led to some surprising first quarter results. In addition, Simon Erickson will update us on the MIT Conference and Matt Cochrane will tell everyone about the $75 billion company you may never have heard of. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

While backup kickers on the Washington State University football team, Brett Schafer and Ryan Henderson used to spend down time talking about stocks. This mutual interest soon blossomed into a regular podcast and website. The first year after they began, Schafer and Henderson report, it was mostly just friends and family listening. But as they began interviewing financial analysts and writers from around the Twitterverse, they quickly gained an audience with their unique blend of youthful humor, hot takes on the market, and solid investment analysis.    The pair are now launching a new fund, Arch Capital. For every position that made it into the portfolio, the pitch ended with the same two questions:    1)Over the next 3-5 years, what are the chances this investment loses money?   2) What chance do you give this stock, at current prices, to compound at 15% over the next 3-5 years?   As Schafer and Henderson like to say, "We start with a margin of safety, and end with growth." The end result is a portfolio with a nice mix of value, growth, and income names. And video games. A lot of video games. In the interview, both Schafer and Henderson talk a little about the video game industry before breaking down one of their top holdings, Nintendo (OTC:NTDOY), a company that probably gets far too less love from American investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Under Armour reported a surprise profit and stong online sales. That bodes well but it does not necessarily mean that the company has turned the corner. Steve Symington joins Dan Kline to discuss. In our second segment, Maxx Chatsko jumps on to talk about “story stocks” and why they’re usually not a great idea. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The big game was yesterday! Which means it’s time to discuss the most important part of the Super Bowl to many – the commercials! Which Super Bowl ads made the biggest impact? Tune in to hear the team’s take, as well as listen as we answer the 3 biggest questions about electric vehicles. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The first chimeric antigen T-Cell Therapy (CAR-T) therapies were approved by the Federal Drug Administration (FDA) in 2017--these were heralded as “cures” for blood-borne cancers such as acute myeloid leukemia and aggressive non-Hodgkin’s Lymphoma. Here, we have Simon Harnest, the Senior Vice President of Corporate Strategy and Finance of Cellectis (CLLS), unpacking where cell therapy is headed towards. Cellectis is the first company  to envision an “off-the-shelf” approach to CAR-T therapy. Previous methods required long manufacturing times and complex methodologies to create a single treatment for a patient.  In this episode, Simon guides us through the complexities of creating an allogeneic approach for developing CAR-T therapies, especially for solid tumors, and addresses why Cellectis is up for the challenge. He also addresses the discrepancy between current valuations of Cellectis and competitor, Moderna (MRNA) who happens to license from Cellectis. This podcast is for anyone interested in learning about the nitty gritty of next generation cancer care from the bottom-up perspective.  Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Jeff Bezos will step down as Amazon CEO and move into an executive chairman role. Andy Jassy, who has headed up the company’s AWS cloud division will become the news boss. What does this mean for investors and will anything really change? We’ll also be digging into the numbers as the company reported strong earnings after the market closed Tuesday.. We’re also taking your questions on pretty much any investing topic. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) might simultaneously have the easiest and most difficult bull case theses for prospective shareholders. Easy: Warren Buffett allocates capital more intelligently than any other investor of the last 100 years. Under his leadership, Berkshire Hathaway shareholders have enjoyed nearly unparalleled success over the last 50 years. With the greatest investor of all-time at the helm, shareholders can sit back and trust him to guide the ship. Difficult: Berkshire Hathaway is an American conglomerate that owns large insurance businesses, railroads, and utilities outright, along with large stakes in American banks, Apple Inc (NASDAQ:AAPL), and Coca-Cola (NYSE:KO). Here to help us cut through the noise and wrap our heads around the incredibly complex business model of the world's largest holding company is Kyler Hasson, a portfolio manager at Delta Investment Management.  Hasson can be found at his blog, Concentrated Compounding, and on Twitter with takes that I always find both entertaining and thoughtful. Hasson discovered Buffett's annual shareholder letters early in his investment journey and has been a shareholder for years. Of Berkshire Hathaway, he says the best way to think of it might be as "a collection of generally high-quality businesses financed in a quite conservative manner … with the common theme sort of being that conservative structure and intelligent capital allocation." As for valuing such a large and intricate business, Hasson admits to keeping a large spreadsheet summing up the value of all its parts, but that many shareholders seem to be able to get just as good of a sense of knowing when shares are particularly expensive or cheap by tracking the company's price-to-book ratio. We also discuss why Buffett missed out on the tech sector's incredible gains of the last decade and what the future might hold for Berkshire Hathaway shareholders after Buffett and Munger are no longer leading the company.